Overview

Natera, Inc. is a diagnostics company, which is focused on the development and commercialization of molecular testing services, applying its technology in the fields of...

Open

$0.00

Prior close

$366.31

Today's high

$0.00

Today's low

$0.00

52 Week high

$366.70

52 Week low

$157.43

News

Business Wire • 1 day ago • NTRA

Largest MRD Study in Lung Cancer Highlights Strong Prognostic Value for SignateraTM

ETF Trends • 16 days ago • NTRA

Why Moderna's Cancer Vaccine Matters to Investors

Business Wire • 18 days ago • NTRA

New Publication Establishes Strong Clinical Validation of Signatera™ for MRD Assessment in Lymphoma

Zacks Investment Research • 21 days ago • NTRA

Natera & Angiex Partner to Evaluate AGX101 Response With Signatera

Business Wire • 21 days ago • NTRA

Natera and Susan G. Komen® Announce National Partnership to Accelerate Progress Against Breast Cancer